# Kaleidoscope of Hope Foundation Inc

Grantmaking public charity, Madison, New Jersey. EIN 22-3744037.

Source: the foundation’s own IRS returns, read November 21, 2026, as shown by the Alleviate Index. https://sites.alleviate.org/index/funder/kaleidoscope-of-hope-foundation-inc-223744037

## Applications

Schedule I of Form 990 lists the grants made, not how to apply, so this return does not say whether Kaleidoscope of Hope Foundation Inc accepts applications.

## What it gave

- Grants paid: $75,000 (Year ending December 2024)
- Grants listed: 3 (To organizations, on that return)
- Typical grant: $25,000 (The median of the grants listed)

- December 2024: Grants paid $75,000; Grants listed 3
- December 2023: Grants paid $152,750; Grants listed 4

From Schedule I of its Form 990 returns for the years ending December 2023 to December 2024.

## What it funds, and where

- Focus, by share of linked grant dollars: Education 100%
- Where it gave, by number of grants: Pennsylvania 2, Georgia 1, Ohio 1, New Jersey 1, Texas 1, New York 1

## Recent grants to organizations

- CORPORATING MERCER UNIVERSITY (Macon, Georgia): $25,000, year ending December 2024. TO SUPPORT OVARIAN CANCER RESEARCH
- [Ohio University Foundation](https://sites.alleviate.org/index/org/ohio-university-foundation-316402269) (Athens, Ohio): $25,000, year ending December 2024. TO SUPPORT OVARIAN CANCER RESEARCH
- TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania): $25,000, year ending December 2024. INVESTIGATION OF A NOVEL P53 STABILIZING TARGETED TREATMENT COMBINATION IN TP53 WILD TYPE OVARIAN CANCER.
- TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (New York, New York): $50,000, year ending December 2023. UNDERSTANDING THE ROLE OF CARM 1 IN REGULATION OF CYTOKINE-MEDIATED ANTITUMOR RESPONSE IN OVARIAN CANCER.
- TRUSTEES OF THE UNIVERISTY OF PENNSYLVANIA (Philadelphia, Pennsylvania): $50,000, year ending December 2023. INVESTIGATION OF A NOVEL P53 STABILIZING TARGETED TREATMENT COMBINATION IN TP53 WILD TYPE OVARIAN CANCER.
- [The Trustees of the Stevens Institute of Technology](https://sites.alleviate.org/index/org/the-trustees-of-the-stevens-institute-of-technology-221487354) (Hoboken, New Jersey): $25,000, year ending December 2023. NUTRITIONAL SUPPLEMENT TAURINE SUPPRESSES OVARIAN CANCER.
- UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER (Houston, Texas): $25,000, year ending December 2023. TO IDENTIFY LIQUID BIOPSY (EXTRACELLULAR VESICLES)BASED MOLECULAR PREDICTORS OF DISEASE PATTERNS FROM PATIENTS FROM MATCHED TISSUES AND BLOOD FROM PATIENTS WITH COMPLETE GROSS RESECTION AND PATIENTS WITH EXCELLENT AND POOR RESPONSE TO CHEMOTHERAPY, FOLLOWED BY CLINICAL VALLIDATION OF OUR FINDING IN PATIENTS WITH HIGHGRADE SEROUS OVARIAN CANCER.

Method and sources: https://sites.alleviate.org/index/method#funders
